Highlights Teva Pharmaceutical Industries Limited TEL AVIV STOCK EXCHANGE

Equities

TEVA

IL0006290147

Market Closed - TEL AVIV STOCK EXCHANGE Other stock markets 10:24:13 2024-07-11 am EDT			5-day change	1st Jan Change
6,211 ^ILa	+4.76%		-1.04%	+62.80%

Jul. 01	Sector Update: Health Care Stocks Retreat Late Afternoon	MT
Jul. 01	Sector Update: Health Care Stocks Slipping in Afternoon Trading	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sector Update: Health Care Stocks Retreat Late Afternoon	Jul. 01	MT
Sector Update: Health Care Stocks Slipping in Afternoon Trading	Jul. 01	MT
Teva Pharmaceuticals Faces FTC Probe on Patent Listings	Jul. 01	MT
Correction: Top Midday Stories: Boeing to Acquire Spirit AeroSystems; Robinhood Acquires Pluto; FTC Probes Teva; BlackRock Acquires Preqin; SCOTUS Grants Trump Some Immunity	Jul. 01	MT
Top Midday Stories: Boeing to Acquire Spirit AeroSystems; Robinhood Acquires Pluto; FTC Probes Teva; BlackRock Acquires Preqin; SCOTUS Grants Trump Some Immunity	Jul. 01	MT
Teva Pharmaceuticals Faces FTC Probe on Patent Listings	Jul. 01	MT
Teva Pharmaceuticals Faces FTC Probe on Patent Listings	Jul. 01	MT
FTC Opens Investigation Into Teva Pharmaceuticals	Jul. 01	MT
Vanda Pharmaceuticals Says Federal Court Allows Patent Lawsuit Over Hetlioz	Jul. 01	MT
Teva Pharmaceutical Industries Ltd Announces New AJOVY® (Fremanezumab) Migraine Prevention Data Challenges Treatment Pauses	Jun. 28	CI
Global markets live: UBS, Boeing, AT&T, Rivian, Nvidia, Tesla...	Jun. 25
Teva Pharmaceutical Pays $750 Million to Resolve Tax-Related Litigation	Jun. 25	MT
Teva settles tax dispute in Israel with $750 mln payment	Jun. 25	RE
Teva Pharmaceutical Industries Limited Announces Launch of Authorized Generic of Victoza® (Liraglutide Injection 1.8Mg), in the United States	Jun. 24	CI
Global markets live: Tesco, Adobe, Tyson Foods, GameStop, Teva...	Jun. 14
Teva Pharmaceutical Sues Corcept Therapeutics Alleging Market Monopolization for Cushing's Syndrome Drug Korlym	Jun. 14	MT
Teva Pharmaceutical Industries Limited Announces AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets Now U.S. FDA Approved as a One Pill, Once-Daily Treatment Option for Clinically Therapeutic Doses (24?48 mg/day)	May. 29	CI
Teva Pharmaceutical Industries Limited and Alvotech Announce SIMLANDI® Injection Now Available in the U.S	May. 20	CI
Sector Update: Health Care Stocks Slipping Wednesday Afternoon	May. 08	MT
Teva Pharmaceutical Shares Rise After Reporting Higher Q1 Earnings, Revenue; 2024 Guidance Reaffirmed	May. 08	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Teva Pharmaceutical Industries isn't out of the woods yet

February 01, 2024 at 04:41 am EST

INTERVIEW - Richard Francis, CEO of Teva Pharmaceutical: solid quarter, full-year forecasts raised

August 02, 2023 at 03:19 pm EDT